Nuclear Medicine

Radnostix reports 27% revenue decline in Q1

By AuntMinnie.com staff writers

Radnostix reported a 27% decrease in the first quarter of 2026 compared to the previous year's first quarter.

May 21, 2026

Niowave breaks ground on $75M Mich. Ac-225 production facility

By AuntMinnie.com staff writers

Niowave has broken ground on its Ac-225 production facility in Lansing, MI, with construction expected to be finished by 2028.

May 21, 2026

NRC to ease burden on radiopharmaceutical licensees

By AuntMinnie.com staff writers

The rule would eliminates decommissioning financial assurance (DFA) for all radionuclides with half-lives of 120 days or less.

May 19, 2026

Plus Therapeutics inks AI deal with Ephemeral Technologies

By AuntMinnie.com staff writers

Plus Therapeutics is a clinical-stage pharmaceutical company developing radiopharmaceutical therapies for CNS cancers.

May 19, 2026

SNMMI highlights new radiopharmaceutical therapy

By AuntMinnie.com staff writers

Mice bearing PDAC xenografts received lutetium-177 (Lu-177) AKIR001, a radiopharmaceutical that targets CD44v6.

May 13, 2026

Eden Radioisotopes files NRC permit for isotope production complex

By AuntMinnie.com staff writers

The company said the facility is designed to produce up to 50% of global demand for molybdenum-99 (Mo-99).

May 6, 2026

C-Ray Therapeutics wins FDA active status for Cu-64 drug master file

By AuntMinnie.com staff writers

C-Ray Therapeutics has received active status from the FDA for its Type II Drug Master File for Cu-64 chloride for radiolabeling.

April 28, 2026

TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies

By AuntMinnie.com staff writers

TAG1 and NRG Pallas aim to develop access to lead-212 (Pb-212) for cancer drug development across Europe.

April 22, 2026

Ionetix raises $30M to scale radioisotope production

By AuntMinnie.com staff writers

The funding will support scaling up of radioisotope production as well as R&D efforts in nuclear energy, materials testing, and related areas.

April 21, 2026

Telix doses first patient in glioblastoma trial

By AuntMinnie.com staff writers

The patient was dosed at Austin Health in Melbourne, Australia.

April 15, 2026

Shine receives $263M conditional loan for Mo-99 isotope facility

By AuntMinnie.com staff writers

Shine has received a conditional loan from the U.S. DOE to complete the Chrysalis medical isotope production facility for Mo-99.

April 9, 2026

First patients treated in RYZ401 radiopharmaceutical trial

By AuntMinnie.com staff writers

RYZ401 is an investigational actinium-225 (AC-225)-based radiopharmaceutical targeting somatostatin receptors in neuroendocrine tumors.

April 8, 2026

Page 1 of 442

Next Page